Previous 10 | Next 10 |
VANCOUVER – BIOTECH INSIDER - New at-home Covid tests are on the way, according to the Biden administration, which announced a new $70 million plan to speed up authorization, especially in the wake of a shortage . A study from Kaiser showed t...
VANCOUVER – Equity Insider - After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the workplace, new problems have arisen, such as expensive testing costs, and rampant supply shortages . On top of that, accuracy issues have also ...
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – New at-home Covid tests are on the way, according to the Biden administration, which announced a new $70 million plan to speed up auth...
The 13 stocks I purchased this month. I focused on consumer staples names in October, as the sector has overreacted to inflation fears. Why I'm not worried about Lockheed Martin. For further details see: IMF October Buys: The 13 Stocks Added To My Fund
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion And Contender Highlights: We...
QIAGEN (NYSE:QGEN) and Becton, Dickinson (NYSE:BDX) have settled a patent infringement lawsuit related to QIAGEN'S NeuMoDx96 and NeuMoDx 288 clinical PCR systems. Becton, Dickinson will receive a one-time payment of $53M. Neither party admitted any wrongdoing. The agreement will not...
Image source: The Motley Fool. Becton, Dickinson and Company (NYSE: BDX) Q4 2021 Earnings Call Nov 4, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Becton, Dickinson and Company (BDX) Q4 2021 Earnings Call Transcr...
Becton, Dickinson and Company (BDX) Q4 2021 Earnings Conference Call November 4, 2021, 8:00 am ET Company Participants Nadia Goncalves - SD, IR Tom Polen - Chairman, CEO & President Chris DelOrefice - EVP &CFO Alberto Mas - President, Medical Segment Simon Campion - President, Interve...
Becton, Dickinson (NYSE:BDX) declares $0.87/share quarterly dividend, 4.8% increase from prior dividend of $0.83. Forward yield 1.41% Payable Dec. 31; for shareholders of record Dec. 10; ex-div Dec. 9. The company has also announced 10M additional share repurchases. This new authorization is ...
Becton, Dickinson (NYSE:BDX): FQ4 Non-GAAP EPS of $2.59 beats by $0.14; GAAP EPS of $0.84 misses by $0.74. Revenue of $5.14B (+7.5% Y/Y) beats by $230M. Press Release BD issues fiscal 2022 guidance of $19.3 to $19.5 billion in revenues and $12.30 to $12.50 adjusted diluted EPS; includes base ...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...